- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Kythera Biopharmaceuticals
Total 878 results
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada, Australia, United Kingdom
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedSubmental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessGermany, France, Belgium, Spain, United Kingdom
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessBelgium, France, Germany, Italy, Spain, United Kingdom
-
OxTheraCompletedPrimary HyperoxaluriaUnited States
-
OxTheraTerminatedHyperoxaluria, PrimaryUnited Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
Keryx BiopharmaceuticalsRecruitingHyperphosphatemia Related to Chronic Kidney DiseaseUnited States
-
Navidea BiopharmaceuticalsRecruitingRheumatoid ArthritisUnited States, United Kingdom
-
Eiger BioPharmaceuticalsCompletedHepatitis Delta VirusUnited States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
-
Eiger BioPharmaceuticalsCompletedPulmonary Arterial HypertensionUnited States, Canada
-
Eiger BioPharmaceuticalsCompletedLymphedemaUnited States, Australia
-
Eiger BioPharmaceuticalsCompleted
-
Eiger BioPharmaceuticalsCompletedPostbariatric HypoglycemiaUnited States
-
Navidea BiopharmaceuticalsActive, not recruitingRheumatoid ArthritisUnited States
-
Eiger BioPharmaceuticalsApproved for marketing
-
Navidea BiopharmaceuticalsCompletedRheumatoid ArthritisUnited States
-
Navidea BiopharmaceuticalsTerminatedParkinson's SyndromeUnited States
-
Keryx BiopharmaceuticalsCompletedAnemia of Chronic Kidney DiseaseIsrael
-
Navidea BiopharmaceuticalsCompletedKaposi's SarcomaUnited States
-
Keryx BiopharmaceuticalsCompletedRenal Failure | End Stage Renal Disease | ESRD | Kidney Failure | HyperphosphatemiaUnited States, Puerto Rico
-
Keryx BiopharmaceuticalsCompletedKidney Failure | HyperphosphatemiaUnited States, Israel, Puerto Rico
-
Navidea BiopharmaceuticalsCompletedMelanoma | Breast CancerUnited States
-
Nabi BiopharmaceuticalsCompletedSmoking Cessation | Nicotine DependenceUnited States
-
Nabi BiopharmaceuticalsCompleted
-
Nabi BiopharmaceuticalsCompleted
-
XTL BiopharmaceuticalsTerminatedChronic Peripheral Neuropathy Pain in DiabeticsUnited States
-
OMRIX BiopharmaceuticalsUnknownBilateral Ovarian DiseaseUnited States, Spain, United Kingdom, Germany
-
Nabi BiopharmaceuticalsCompletedArteriosclerosis | Hyperparathyroidism, Secondary | CalcinosisUnited States
-
Nabi BiopharmaceuticalsTerminatedEvaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease (SHIELD-2)Staphylococcal Infections | Chronic Kidney FailureUnited States
-
Keryx BiopharmaceuticalsNot yet recruitingIron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease